文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

美国老年医保受益人中行动辅具使用与行动障碍:癌症史与非癌症史比较

Mobility Device Use and Mobility Disability in U.S. Medicare Beneficiaries With and Without Cancer History.
PubMed 文献 · J Am Geriatr Soc · 2020-09-24

BACKGROUND/OBJECTIVES: To examine the prevalence of mobility device use in U.S. community-dwelling older adults including older adults with cancer history ("survivors") and to estimate mobility disability noting variation by cancer history, cancer site, and other factors to impro…

要点

  • 癌症幸存者行动辅具使用率高于无癌症史者(23% vs 19%)。
  • 既往辅具使用、多次跌倒、不健康体重、黑人种族、多病共存和活动受限疼痛与较低步速评分相关。

核心结论

  • 老年癌症幸存者使用行动辅具的比例高于无癌症史者,且更可能表现出行走速度相关的行动障碍迹象。

研究设计与样本

  • 2011年美国国家健康与老龄化趋势研究(NHATS)的横断面分析,全国代表性社区居住65岁及以上Medicare受益人样本n=6,080,其中癌症幸存者1,203人。

主要发现

  • 19%的老年人和23%的幸存者报告使用一种或多种行动辅具,最常用单点手杖。
  • 约10%乳腺癌、6%前列腺癌和3%结直肠癌幸存者报告过去一个月使用两种或以上辅具。
  • 幸存者平均步速评分为2.27,低于无癌症史者的2.39。

关键数值与推荐

  • 步速测试结果按0至4分评分(0=最低,4=最高),采用国家老龄化研究所标准。
  • 行动辅具使用率:老年人19%,幸存者23%;乳腺癌幸存者约10%、前列腺癌6%、结直肠癌3%使用两种或以上辅具。

临床怎么用

  • 对老年癌症幸存者应关注行动辅具使用及步速变化,以及时发现行动障碍。
  • 评估时应考虑既往辅具使用、多次跌倒、不健康体重、多病共存和活动受限疼痛等关联因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: To examine the prevalence of mobility device use in U.S. community-dwelling older adults including older adults with cancer history ("survivors") and to estimate mobility disability noting variation by cancer history, cancer site, and other factors to improve early detection of mobility limitations. DESIGN: Cross-sectional analysis from the 2011 National Health and Aging Trends Study. SETTING: In-person interviews in the homes of study participants. PARTICIPANTS: Nationally representative sample of community-dwelling Medicare beneficiaries, aged 65 and older (n = 6,080 including 1,203 survivors). MEASUREMENTS: Participants were asked about cancer history, pain that limited activity, mobility device use (eg, canes, walkers, wheelchairs, and scooters), history of falls, and medical conditions plus they were assessed for approximate mobility disability using a 3-m gait speed test. The results were scored on a scale of 0 to 4 (0 = lowest, 4 = highest) using criteria from the National Institute on Aging. RESULTS: A total of 19% of older adults and 23% of survivors reported using one or more mobility device, most commonly a single-point cane. Approximately 10% of breast, 6% of prostate, and 3% of colorectal cancer survivors reported using two or more devices in the past month. Survivors had lower mean gait speed scores (2.27) than adults without cancer history (2.39). In regression models, survivors were 18% less likely than adults without cancer history to score high on the gait speed test (odds ratio = .82; P < .05). Prior mobility device use, history of multiple falls, unhealthy weight, Black race, multimorbidity, and pain that limited activity were associated with lower gait speed scores in all participants (all P < .05). CONCLUSION: A greater proportion of older survivors used mobility devices than adults without cancer history. Mobility device use varied by cancer site and was highest in survivors of breast, colorectal, and gynecological cancer. Survivors were also more likely to show signs of mobility disability, based on gait speed, compared with adults without cancer history. These indications, although modest, suggest that older survivors may require special attention to functional changes in survivorship.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Bluethmann SM, Flores E, Campbell G, et al. Mobility Device Use and Mobility Disability in U.S. Medicare Beneficiaries With and Without Cancer History. J Am Geriatr Soc. 2020. PMID: 32971567. doi:10.1111/jgs.16789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。